225 related articles for article (PubMed ID: 33303555)
1. High eosinophil counts predict decline in FEV
Tan WC; Bourbeau J; Nadeau G; Wang W; Barnes N; Landis SH; Kirby M; Hogg JC; Sin DD; ;
Eur Respir J; 2021 May; 57(5):. PubMed ID: 33303555
[TBL] [Abstract][Full Text] [Related]
2. The association of blood eosinophil counts and FEV
Hong YS; Park HY; Ryu S; Shin SH; Zhao D; Singh D; Guallar E; Cho J; Chang Y; Lim SY
Eur Respir J; 2024 May; 63(5):. PubMed ID: 38636990
[TBL] [Abstract][Full Text] [Related]
3. Blood Leukocyte Concentrations, FEV
Zeig-Owens R; Singh A; Aldrich TK; Hall CB; Schwartz T; Webber MP; Cohen HW; Kelly KJ; Nolan A; Prezant DJ; Weiden MD
Ann Am Thorac Soc; 2018 Feb; 15(2):173-183. PubMed ID: 29099614
[TBL] [Abstract][Full Text] [Related]
4. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
Siddiqui SH; Pavord ID; Barnes NC; Guasconi A; Lettis S; Pascoe S; Petruzzelli S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3669-3676. PubMed ID: 30464449
[TBL] [Abstract][Full Text] [Related]
5. Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma.
Sposato B; Scalese M; Ricci A; Rogliani P; Paggiaro P;
Clin Respir J; 2021 Feb; 15(2):237-243. PubMed ID: 33400385
[TBL] [Abstract][Full Text] [Related]
6. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids, blood eosinophils, and FEV
Whittaker HR; Müllerova H; Jarvis D; Barnes NC; Jones PW; Compton CH; Kiddle SJ; Quint JK
Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788
[No Abstract] [Full Text] [Related]
8. Type-2 inflammation and lung function decline in chronic airway disease in the general population.
Çolak Y; Afzal S; Marott JL; Vestbo J; Nordestgaard BG; Lange P
Thorax; 2024 Mar; 79(4):349-358. PubMed ID: 38195642
[TBL] [Abstract][Full Text] [Related]
9. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
[TBL] [Abstract][Full Text] [Related]
10. Association between COPD exacerbations and lung function decline during maintenance therapy.
Kerkhof M; Voorham J; Dorinsky P; Cabrera C; Darken P; Kocks JW; Sadatsafavi M; Sin DD; Carter V; Price DB
Thorax; 2020 Sep; 75(9):744-753. PubMed ID: 32532852
[TBL] [Abstract][Full Text] [Related]
11. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
[TBL] [Abstract][Full Text] [Related]
12. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
[TBL] [Abstract][Full Text] [Related]
13. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
[TBL] [Abstract][Full Text] [Related]
14. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.
Ko FWS; Chan KP; Ngai J; Ng SS; Yip WH; Ip A; Chan TO; Hui DSC
Respirology; 2020 Mar; 25(3):259-266. PubMed ID: 31385389
[TBL] [Abstract][Full Text] [Related]
15. Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis.
Ye SC; Desai S; Karlsen E; Kwong E; Wilcox PG; Quon BS
J Cyst Fibros; 2022 Nov; 21(6):1048-1052. PubMed ID: 35370086
[TBL] [Abstract][Full Text] [Related]
16. Associations between blood eosinophils and decline in lung function among adults with and without asthma.
Hancox RJ; Pavord ID; Sears MR
Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29563173
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors of Rapid FEV1 Decline in a Real-World Chronic Obstructive Pulmonary Disease Cohort.
Lee HW; Lee JK; Lee MG; Shin KC; Ra SW; Kim TH; Hwang YI; Jung KS; Yoo KH; Kim DK
Respiration; 2022; 101(12):1078-1087. PubMed ID: 36349793
[TBL] [Abstract][Full Text] [Related]
18. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.
Vedel-Krogh S; Nordestgaard BG; Lange P; Vestbo J; Nielsen SF
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29650563
[TBL] [Abstract][Full Text] [Related]
19. Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study.
Park HY; Chang Y; Kang D; Hong YS; Zhao D; Ahn J; Shin SH; Singh D; Guallar E; Cho J; Ryu S
Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33737406
[TBL] [Abstract][Full Text] [Related]
20. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
